PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients
The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.
UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics
“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman.
Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer
One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.
Some PET exams may be overutilized in oncology
In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.
PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.

MRI and PET findings could guide treatment of lingering concussion symptoms

Abnormalities of the thalamus could be to blame for persistent symptoms in the months following a concussion, according to new research.

Imaging required to monitor effects of new Alzheimer's drug could inhibit its uptake

Leqembi can cause amyloid-related imaging abnormalities (ARIA), which must be assessed on imaging.

Imaging considerations included in tattoo guidelines for at-risk cancer population

Cases of mistaken malignancy have become more common as the popularity of tattoos has grown in recent years.

PET/MRI of FAPI radiotracer uptake in Crohn's disease

New imaging technique could change how Crohn's disease is treated

The FAPI radiotracer experts used in this research can bind specifically to the connective tissue cells that cause intestinal wall fibrosis common to Crohn's disease.

Advanced imaging does not always improve outcomes, data suggest

Although advanced imaging exams have proven benefits in defining disease severity, new data indicate that more sophisticated studies might not impact outcomes as much as previously thought.

New practice guidelines for PET imaging of neuroendocrine tumors

Issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM), the new guidelines are intended to inform any practitioners involved in ordering, performing, reading and reporting SSTR PET imaging.

Amyloid plaque patterns on PET imaging predict Alzheimer's progression in asymptomatic patients

Experts involved in the new research suggest that identifying these spatiotemporal variations could play an important role in clinical research and precision medicine.

E-cigarettes cause worse inflammation than tobacco cigarettes, new PET data shows

The use of e-cigarettes has increased significantly in recent years, mostly due to the fact that many consumers believe them to be a safer option than traditional cigarettes.

PET/CT

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

Some PET exams may be overutilized in oncology

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients